Xelpmoc Design and Tech has scheduled its 11th Annual General Meeting for September 30, 2026. The meeting will seek shareholder approval for a new 2026 Employees Stock Option Scheme. As the company transitions from a startup incubator to an enterprise product-led model, investors are watching the commercial adoption of its platforms, DocuXray and RELY, to drive future profitability.
Xelpmoc Design and Tech Sets AGM Date and Product Focus
Revenue from operations stood at Rs 3.73 crore with a net loss of Rs 7.59 crore for FY26.
Reader Takeaway: Xelpmoc pivots to product-led model for growth while addressing liquidity and scaling enterprise platform adoption.
What just happened
Xelpmoc Design and Tech Limited has officially scheduled its 11th Annual General Meeting (AGM) for September 30, 2026. The company has designated September 23, 2026, as the cut-off date to determine shareholder eligibility for remote e-voting. Key agenda items include the adoption of the audited financial statements for FY26 and the formal approval of the 'Xelpmoc Design and Tech Limited Employees Stock Option Scheme – 2026'.
Why this matters
The company is executing a strategic pivot away from its legacy startup incubation model toward becoming a pure-play enterprise software product firm. This shift is centered on two proprietary platforms: DocuXray, an AI-driven document intelligence tool, and RELY, an AgeTech platform. Success in these segments is critical, as management reports these products recorded their first commercial engagements during the fiscal year, and future growth is tied to their market scaling.
The backstory
For the financial year ended March 31, 2026, Xelpmoc reported revenue of Rs 3.73 crore compared to Rs 3.90 crore in the prior year. While the company remains in a net loss position at Rs 7.59 crore, these losses have narrowed from the Rs 8.07 crore reported in FY25. The company also strengthened its balance sheet via a partial divestment of its stake in Mihup Communications, generating Rs 10 crore in cash.
What changes now
Shareholders will vote on special resolutions regarding the new ESOP 2026 scheme, which includes provisions for extending the program to employees of subsidiary companies and allowing for significant option grants to identified employees. These measures are designed to align leadership and staff with the company's long-term transition into an enterprise-focused software developer.
Risks to watch
Investors should monitor the company's financial runway, which is currently estimated at 10–12 months. Management has acknowledged that the enterprise-focused AI solutions face long sales cycles, which continues to impact the velocity of revenue growth and the overall timeline to achieve profitability.
What to track next
Watch for updates on the adoption metrics for DocuXray and RELY. Future quarterly disclosures regarding commercial contracts and revenue contribution from these proprietary platforms will be the primary indicators of success for the company's new strategic direction.
